Concepedia

Author

Kehinde Adekola

Fred Hutch Cancer CenterORCID

Also Known As

K Adekola, K. Adekola, Kehinde Adekola, Kehinde U A Adekola, Kehinde U. A. Adekola, Kehinde U. Adekola, Kehinde U.A. Adekola, Kehinde. U. A. Adekola

72

Publications

2.2K

Citations

20

H-Index

46

Concepts

All Affiliations

Fred Hutch Cancer CenterNorthwestern UniversityMemorial Sloan Kettering Cancer CenterThe University of Texas MD Anderson Cancer CenterUniversity of Pennsylvania
KA

About

Kehinde Adekola is an author at Fred Hutch Cancer Center specializing in medicine, health sciences, and cancer research.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

9

9

768

2

Health Sciences

6

6

687

3

Biochemistry

2

2

69

4

Public Health

1

1

18

5

Blood Transplantation

1

1

18

Kehinde Adekola

×

24

Publications

1.5K

Citations

19

H-Index

YearCitations

Increasing use of allogeneic hematopoietic cell transplantation in patients aged 70 years and older in the United States

Lori Muffly, Marcelo C. Pasquini, Michael J. Martens,

Blood

2017

281

Multiple Myeloma, Version 3.2021, NCCN Clinical Practice Guidelines in Oncology

Shaji Kumar, Natalie S. Callander, Kehinde Adekola,

Journal of the National Comprehensive Cancer Network

2020

273

NCCN Guidelines® Insights: Multiple Myeloma, Version 3.2022

Natalie S. Callander, Muhamed Baljević, Kehinde Adekola,

Journal of the National Comprehensive Cancer Network

2022

200

Targeting the Metabolic Plasticity of Multiple Myeloma with FDA-Approved Ritonavir and Metformin

Sevim Dalva-Aydemir, Richa Bajpai, Maylyn Martinez,

Clinical Cancer Research

2014

139

Multiple Myeloma, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology

Shaji Kumar, Natalie S. Callander, Kehinde Adekola,

Journal of the National Comprehensive Cancer Network

2023

127

Investigating and targeting chronic lymphocytic leukemia metabolism with the human immunodeficiency virus protease inhibitor ritonavir and metformin

Kehinde Adekola, Sevim Dalva-Aydemir, Shuo Ma,

Leukemia & lymphoma/Leukemia and lymphoma

2014

49

Can a Female Donor for a Male Recipient Decrease the Relapse Rate for Patients with Acute Myeloid Leukemia Treated with Allogeneic Hematopoietic Stem Cell Transplantation?

Piyanuch Kongtim, Antonio Di Stasi, Gabriela Rondón,

Biology of Blood and Marrow Transplantation

2014

44

Multisite 11-year experience of less-intensive vs intensive therapies in acute myeloid leukemia

Mohamed L. Sorror, Barry E. Storer, Amir T. Fathi,

Blood

2021

44

Systemic Light Chain Amyloidosis, Version 2.2023, NCCN Clinical Practice Guidelines in Oncology.

Shaji Kumar, Natalie S. Callander, Kehinde Adekola,

PubMed

2023

43

Allogeneic Hematopoietic Cell Transplantation for Adult T Cell Acute Lymphoblastic Leukemia

Betty K. Hamilton, Lisa Rybicki, Donna Abounader,

Biology of Blood and Marrow Transplantation

2017

35

Page 1